---
title: "Dogwood Therapeutics, Inc. (DWTX.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/DWTX.US.md"
symbol: "DWTX.US"
name: "Dogwood Therapeutics, Inc."
industry: "Biotechnology"
---

# Dogwood Therapeutics, Inc. (DWTX.US)

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Location | US Market |
| Website | [dwtx.com](https://dwtx.com) |

## Company Profile

Dogwood Therapeutics, Inc., a development-stage biotechnology company, focuses on the development of medicine to treat pain and fatigue-related disorders. Its lead product candidates include IMC-1, a fixed dose combination of famciclovir and celecoxib that has completed Phase 2b clinical trial to tr...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -2.35 | 272/604 | - | - | - |
| PB | -2.84 | 507/604 | 10.85 | 7.18 | 6.24 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-02-20T05:00:00.000Z

Total Analysts: **3**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 1 | 33% |
| Overweight | 1 | 33% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 2.93 |
| Highest Target | 30.00 |
| Lowest Target | 11.69 |

## References

- [Company Overview](https://longbridge.com/en/quote/DWTX.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/DWTX.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/DWTX.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.
